Do analysts recommend COTY or NUS?

Coty presently has a consensus target price of $3.70, indicating a potential upside of 34.43%. Given Coty's stronger consensus rating and higher probable upside, analysts clearly believe Coty is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Coty 3 Sell rating(s) 13 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.88 Nu Skin Enterprises 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media favor COTY or NUS?

In the previous week, Coty had 3 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 4 mentions for Coty and 1 mentions for Nu Skin Enterprises. Coty's average media sentiment score of 0.66 beat Nu Skin Enterprises' score of 0.00 indicating that Coty is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Coty 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nu Skin Enterprises 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate USNA or NUS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Nu Skin Enterprises 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media favor USNA or NUS?

In the previous week, USANA Health Sciences had 4 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 5 mentions for USANA Health Sciences and 1 mentions for Nu Skin Enterprises. USANA Health Sciences' average media sentiment score of 0.39 beat Nu Skin Enterprises' score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nu Skin Enterprises 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer NUS or NATR?

Nature's Sunshine Products has a consensus price target of $34.50, suggesting a potential upside of 71.22%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts clearly believe Nature's Sunshine Products is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Nature's Sunshine Products 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00

Does the media prefer NUS or NATR?

In the previous week, Nature's Sunshine Products had 2 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 3 mentions for Nature's Sunshine Products and 1 mentions for Nu Skin Enterprises. Nature's Sunshine Products' average media sentiment score of 0.39 beat Nu Skin Enterprises' score of 0.00 indicating that Nature's Sunshine Products is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nu Skin Enterprises 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nature's Sunshine Products 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer NUS or MED?

Medifast has a consensus target price of $12.00, suggesting a potential upside of 22.14%. Given Medifast's stronger consensus rating and higher probable upside, analysts plainly believe Medifast is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Medifast 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Does the media favor NUS or MED?

In the previous week, Medifast had 4 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 5 mentions for Medifast and 1 mentions for Nu Skin Enterprises. Medifast's average media sentiment score of 0.36 beat Nu Skin Enterprises' score of 0.00 indicating that Medifast is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nu Skin Enterprises 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Medifast 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer NUS or VERU?

Veru has a consensus price target of $23.00, suggesting a potential upside of 926.79%. Given Veru's stronger consensus rating and higher probable upside, analysts clearly believe Veru is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Veru 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has higher earnings & valuation, NUS or VERU?

Nu Skin Enterprises has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nu Skin Enterprises $1.49B 0.17 $160.20M $1.10 4.71 Veru $16.89M 2.13 -$22.73M -$0.89 N/A

Is NUS or VERU more profitable?

Nu Skin Enterprises has a net margin of 3.78% compared to Veru's net margin of 0.00%. Nu Skin Enterprises' return on equity of 7.47% beat Veru's return on equity. Company Net Margins Return on Equity Return on Assets Nu Skin Enterprises 3.78% 7.47% 4.21% Veru N/A -54.72% -39.09%

Does the media refer more to NUS or VERU?

In the previous week, Veru had 3 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 4 mentions for Veru and 1 mentions for Nu Skin Enterprises. Veru's average media sentiment score of 0.74 beat Nu Skin Enterprises' score of 0.00 indicating that Veru is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nu Skin Enterprises 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Veru 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Nu Skin Enterprises (NUS) Competitors

$5.18 -0.01 (-0.17%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$5.19 +0.01 (+0.25%)

As of 07/31/2026 07:21 PM Eastern

Compare

NUS vs. COTY, USNA, NATR, MED, and VERU

Should you buy Nu Skin Enterprises stock or one of its competitors? MarketBeat compares Nu Skin Enterprises with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nu Skin Enterprises include Coty (COTY), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), Medifast (MED), and Veru (VERU).

How does Nu Skin Enterprises compare to Coty?

Coty (NYSE:COTY) and Nu Skin Enterprises (NYSE:NUS) are both consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Coty has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.98, meaning that its share price is 2% less volatile than the broader market.

Nu Skin Enterprises has a net margin of 3.78% compared to Coty's net margin of -9.20%. Nu Skin Enterprises' return on equity of 7.47% beat Coty's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Coty	-9.20%	4.59%	1.47%
Nu Skin Enterprises	3.78%	7.47%	4.21%

Coty presently has a consensus target price of $3.70, indicating a potential upside of 34.43%. Given Coty's stronger consensus rating and higher probable upside, analysts clearly believe Coty is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Coty	3 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88
Nu Skin Enterprises	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

42.4% of Coty shares are owned by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are owned by institutional investors. 5.9% of Coty shares are owned by insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Coty had 3 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 4 mentions for Coty and 1 mentions for Nu Skin Enterprises. Coty's average media sentiment score of 0.66 beat Nu Skin Enterprises' score of 0.00 indicating that Coty is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Coty	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nu Skin Enterprises	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nu Skin Enterprises has lower revenue, but higher earnings than Coty. Coty is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Coty	$5.89B	0.41	-$367.90M	-$0.62	N/A
Nu Skin Enterprises	$1.49B	0.17	$160.20M	$1.10	4.71

Summary

Coty and Nu Skin Enterprises tied by winning 8 of the 16 factors compared between the two stocks.

How does Nu Skin Enterprises compare to USANA Health Sciences?

USANA Health Sciences (NYSE:USNA) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Nu Skin Enterprises has a net margin of 3.78% compared to USANA Health Sciences' net margin of 0.96%. Nu Skin Enterprises' return on equity of 7.47% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Nu Skin Enterprises	3.78%	7.47%	4.21%

Nu Skin Enterprises has higher revenue and earnings than USANA Health Sciences. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.44	$10.76M	$0.47	46.95
Nu Skin Enterprises	$1.49B	0.17	$160.20M	$1.10	4.71

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Nu Skin Enterprises	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, USANA Health Sciences had 4 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 5 mentions for USANA Health Sciences and 1 mentions for Nu Skin Enterprises. USANA Health Sciences' average media sentiment score of 0.39 beat Nu Skin Enterprises' score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nu Skin Enterprises	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

USANA Health Sciences has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market.

Summary

Nu Skin Enterprises beats USANA Health Sciences on 8 of the 13 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Nature's Sunshine Products?

Nu Skin Enterprises (NYSE:NUS) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

Nu Skin Enterprises has a beta of 0.98, indicating that its share price is 2% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market.

Nu Skin Enterprises has higher revenue and earnings than Nature's Sunshine Products. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.49B	0.17	$160.20M	$1.10	4.71
Nature's Sunshine Products	$480.14M	0.74	$19.52M	$1.10	18.32

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nature's Sunshine Products has a net margin of 4.06% compared to Nu Skin Enterprises' net margin of 3.78%. Nature's Sunshine Products' return on equity of 14.67% beat Nu Skin Enterprises' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
Nature's Sunshine Products	4.06%	14.67%	9.27%

Nature's Sunshine Products has a consensus price target of $34.50, suggesting a potential upside of 71.22%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts clearly believe Nature's Sunshine Products is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Nature's Sunshine Products	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

In the previous week, Nature's Sunshine Products had 2 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 3 mentions for Nature's Sunshine Products and 1 mentions for Nu Skin Enterprises. Nature's Sunshine Products' average media sentiment score of 0.39 beat Nu Skin Enterprises' score of 0.00 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nu Skin Enterprises	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nature's Sunshine Products	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Nature's Sunshine Products beats Nu Skin Enterprises on 12 of the 16 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Medifast?

Nu Skin Enterprises (NYSE:NUS) and Medifast (NYSE:MED) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 95.5% of Medifast shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by company insiders. Comparatively, 3.7% of Medifast shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Nu Skin Enterprises has a net margin of 3.78% compared to Medifast's net margin of -5.78%. Nu Skin Enterprises' return on equity of 7.47% beat Medifast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
Medifast	-5.78%	-4.80%	-3.83%

Nu Skin Enterprises has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.49B	0.17	$160.20M	$1.10	4.71
Medifast	$385.79M	0.28	-$18.67M	-$1.83	N/A

Medifast has a consensus target price of $12.00, suggesting a potential upside of 22.14%. Given Medifast's stronger consensus rating and higher probable upside, analysts plainly believe Medifast is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Medifast	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Nu Skin Enterprises has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market. Comparatively, Medifast has a beta of 0.65, suggesting that its stock price is 35% less volatile than the broader market.

In the previous week, Medifast had 4 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 5 mentions for Medifast and 1 mentions for Nu Skin Enterprises. Medifast's average media sentiment score of 0.36 beat Nu Skin Enterprises' score of 0.00 indicating that Medifast is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nu Skin Enterprises	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Medifast	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Nu Skin Enterprises and Medifast tied by winning 8 of the 16 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Veru?

Nu Skin Enterprises (NYSE:NUS) and Veru (NASDAQ:VERU) are related small-cap companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Nu Skin Enterprises has a net margin of 3.78% compared to Veru's net margin of 0.00%. Nu Skin Enterprises' return on equity of 7.47% beat Veru's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
Veru	N/A	-54.72%	-39.09%

Nu Skin Enterprises has a beta of 0.98, meaning that its share price is 2% less volatile than the broader market. Comparatively, Veru has a beta of -1.15, meaning that its share price is 215% less volatile than the broader market.

Veru has a consensus price target of $23.00, suggesting a potential upside of 926.79%. Given Veru's stronger consensus rating and higher probable upside, analysts clearly believe Veru is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Veru	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Nu Skin Enterprises has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.49B	0.17	$160.20M	$1.10	4.71
Veru	$16.89M	2.13	-$22.73M	-$0.89	N/A

In the previous week, Veru had 3 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 4 mentions for Veru and 1 mentions for Nu Skin Enterprises. Veru's average media sentiment score of 0.74 beat Nu Skin Enterprises' score of 0.00 indicating that Veru is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nu Skin Enterprises	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Veru	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

82.8% of Nu Skin Enterprises shares are held by institutional investors. Comparatively, 47.2% of Veru shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by company insiders. Comparatively, 14.2% of Veru shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Nu Skin Enterprises beats Veru on 9 of the 16 factors compared between the two stocks.

Get Nu Skin Enterprises News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NUS vs. The Competition

Export

Metric	Nu Skin Enterprises	Personal Care Products Industry	Consumer Staples Sector	NYSE Exchange
Market Cap	$251.54M	$22.77B	$16.22B	$23.67B
Dividend Yield	4.62%	4.23%	3.20%	4.22%
P/E Ratio	4.71	18.31	14.58	31.00
Price / Sales	0.17	12.82	262,279.64	19.22
Price / Cash	2.15	16.74	56.11	18.73
Price / Book	0.31	2.93	4.94	4.76
Net Income	$160.20M	$1.08B	$841.31M	$1.07B
7 Day Performance	1.21%	-1.15%	0.72%	-0.34%
1 Month Performance	3.10%	-4.75%	-0.83%	-0.53%
1 Year Performance	-36.74%	-18.81%	13.45%	19.19%

Nu Skin Enterprises Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NUS Nu Skin Enterprises	2.3373 of 5 stars	$5.18 -0.2%	N/A	-36.7%	$251.54M	$1.49B	4.71	2,800	News Coverage Upcoming Earnings
COTY Coty	3.9834 of 5 stars	$2.71 +3.6%	$3.70 +36.9%	-41.6%	$2.30B	$5.89B	N/A	11,636
USNA USANA Health Sciences	1.9089 of 5 stars	$22.39 +2.6%	N/A	-23.5%	$402.86M	$925.26M	47.63	1,570	Upcoming Earnings
NATR Nature's Sunshine Products	3.4963 of 5 stars	$20.96 +2.6%	$35.00 +67.0%	+27.5%	$359.26M	$489.79M	19.05	850	News Coverage Positive News Upcoming Earnings
MED Medifast	3.3306 of 5 stars	$10.42 +1.6%	$12.00 +15.2%	-28.4%	$114.08M	$385.79M	N/A	870

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NUS) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nu Skin Enterprises (NUS) Competitors

NUS vs. COTY, USNA, NATR, MED, and VERU

How does Nu Skin Enterprises compare to Coty?

Summary

How does Nu Skin Enterprises compare to USANA Health Sciences?

Summary

How does Nu Skin Enterprises compare to Nature's Sunshine Products?

Summary

How does Nu Skin Enterprises compare to Medifast?

Summary

How does Nu Skin Enterprises compare to Veru?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUS vs. The Competition

Nu Skin Enterprises Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nu Skin Enterprises (NUS) Competitors

NUS vs. COTY, USNA, NATR, MED, and VERU

How does Nu Skin Enterprises compare to Coty?

Which has more risk & volatility, COTY or NUS?

Is COTY or NUS more profitable?

Do analysts recommend COTY or NUS?

Do insiders and institutionals believe in COTY or NUS?

Does the media favor COTY or NUS?

Which has better valuation & earnings, COTY or NUS?

Summary

How does Nu Skin Enterprises compare to USANA Health Sciences?

Is USNA or NUS more profitable?

Which has better valuation and earnings, USNA or NUS?

Do analysts rate USNA or NUS?

Do institutionals & insiders hold more shares of USNA or NUS?

Does the media favor USNA or NUS?

Which has more risk & volatility, USNA or NUS?

Summary

How does Nu Skin Enterprises compare to Nature's Sunshine Products?

Which has more volatility and risk, NUS or NATR?

Which has better earnings and valuation, NUS or NATR?

Do institutionals and insiders hold more shares of NUS or NATR?

Is NUS or NATR more profitable?

Do analysts prefer NUS or NATR?

Does the media prefer NUS or NATR?

Summary

How does Nu Skin Enterprises compare to Medifast?

Do institutionals & insiders hold more shares of NUS or MED?

Is NUS or MED more profitable?

Which has preferable valuation and earnings, NUS or MED?

Do analysts prefer NUS or MED?

Which has more volatility & risk, NUS or MED?

Does the media favor NUS or MED?

Summary

How does Nu Skin Enterprises compare to Veru?

Is NUS or VERU more profitable?

Which has more volatility and risk, NUS or VERU?

Do analysts prefer NUS or VERU?

Which has higher earnings & valuation, NUS or VERU?

Does the media refer more to NUS or VERU?

Do institutionals and insiders have more ownership in NUS or VERU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUS vs. The Competition

Nu Skin Enterprises Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools